James R. Neal

Companies

• Akari Therapeutics PlcBoard member Nov 22, 2024 to now¹
• Processa Pharmaceuticals, Inc.Board member Jul 21, 2022 to now²
• Peak Bio, Inc.Board member Nov 3, 2022 to Nov 18, 2024³
• PALISADE BIO, INC.Board member Apr 29, 2021 to Feb 13, 2024⁴
• XOMA Royalty CorpChief executive officer May 22, 2017 to Jul 18, 2022⁵
• XOMA Royalty CorpBoard member Mar 23, 2017 to Jul 18, 2022⁶
• Monterey Innovation Acquisition CorpBoard member Sep 30, 2021 to Sep 30, 2021⁷
• XOMA Royalty CorpVP Business Development Mar 3, 2014 to Nov 3, 2016⁸

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• ATAkari Therapeutics Plc AKTX36,271 shares⁹$303.6K at $8.37Mar 24, 2025
• PBPALISADE BIO, INC. PALI10,920 shares¹⁰$14.6K at $1.33Feb 9, 2024
• PPProcessa Pharmaceuticals, Inc. PCSA1,021 shares¹¹$1.8K at $1.73Jul 28, 2026
• XRXOMA Royalty Corp19,822 shares¹²Jul 18, 2022
• PBPeak Bio, Inc.0 shares¹³Nov 14, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

• Jun 26, 2026Exercised options 203 shares of Processa Pharmaceuticals, Inc.¹⁴
• Mar 31, 2026Bought 789 shares at $2.54 of Processa Pharmaceuticals, Inc.¹⁵
• Mar 6, 2025Granted 4,464 shares at $1.12 of Akari Therapeutics Plc¹⁶
• Jan 9, 2025Granted 8,000,000 shares of Akari Therapeutics Plc¹⁷
• Dec 23, 2024Granted 2,000,000 shares of Akari Therapeutics Plc¹⁸
• Nov 14, 2024Returned to company 37,850 shares of Peak Bio, Inc.¹³
• Nov 14, 2024Converted 37,850 shares of Peak Bio, Inc.¹³
• Feb 9, 2024Exercised options 5,820 shares of PALISADE BIO, INC.¹⁰
• Feb 9, 2024Exercised options 5,100 shares of PALISADE BIO, INC.¹⁰
• Jun 27, 2023Exercised options 14,407 shares of Processa Pharmaceuticals, Inc.¹⁹
• Jul 15, 2022Sold 905 shares at $31.86 of XOMA Royalty Corp¹²
• Jul 15, 2022Sold 3,212 shares at $31.19 of XOMA Royalty Corp¹²
• Jul 15, 2022Sold 20,883 shares at $29.55 of XOMA Royalty Corp¹²
• Jul 15, 2022Exercised options 25,000 shares at $4.03 of XOMA Royalty Corp¹²
• Mar 23, 2022Sold 1,111 shares at $30.02 of XOMA Royalty Corp²⁰
• Mar 23, 2022Exercised options 1,111 shares at $4.03 of XOMA Royalty Corp²⁰
• Mar 22, 2022Sold 2,339 shares at $30.02 of XOMA Royalty Corp²⁰
• Mar 22, 2022Exercised options 2,339 shares at $4.03 of XOMA Royalty Corp²⁰
• Mar 21, 2022Sold 50,000 shares at $29.01 of XOMA Royalty Corp²⁰
• Mar 21, 2022Exercised options 50,000 shares at $4.03 of XOMA Royalty Corp²⁰